National price negotiation of hospital-only medicinal products is not an auction
HUS Pharmacy Director Kerstin Carlsson reveals the process of national price negotiation of hospital-only medicinal...
HUS Pharmacy Director Kerstin Carlsson reveals the process of national price negotiation of hospital-only medicinal...
Real-world data on diffuse large B-cell lymphoma (DLBCL) has remained incomplete. In Finland, electronic health...
We start this year in the world of methodologies with a hot topic of utilizing...
Medaffcon expands its network of companies to Omicron ApS and Value Coaching Oy to extend...
With the ninth Health from Data blog post and the end of the year closing...
A real-world evidence (RWE) study makes visible what happens to a group of patients in...
We took the first glimpse into the world of methodologies earlier this year when Medaffcon’s...
The Finnish health and social care registries are unique from an international perspective. Thus, real-world...
Research has shown that osteoarthritis causes disability, especially among older adults. Our latest real-world evidence...
Real-world evidence (RWE) is relatively young. However, RWE-research has its roots in the traditional registry-based...
OSLO, Norway/ ESPOO, Finland May 24, 2021 LINK Medical, the Northern European clinical research organization...
This series of featuring blog posts aims to open the world of data analysis methodologies....
DLIMI and Medaffcon join forces to provide research-based pharmaceutical companies with Nordic Real World Evidence...
Multiple myeloma (MM) is a hematologic cancer displaying an abnormal heterogenous B cell population in...
Real-world evidence is gaining interest – and fast. The phenomenon is global. The growth of...
A prototype of a Gaucher disease point-scoring system (PSS), originally established by the Gaucher Earlier...
Year 2021 will be the year of Real-World Evidence. Data obtained from patients’ treatment has...
This March marks the start of my new blog – Health From Data. Here I...
Interested in RWE research? Health from data is the first real-world evidence themed blog written...
Real World Evidence (RWE) ecosystem in Finland Real world data (RWD) is defined by FDA...
Medicines in Finland are divided into medicines in ambulatory and hospital care. This article describes...
Migraine is a disabling headache disorder that places a significant burden both for the patients...
The real world data (RWD) landscape in Finland offers globally unique data and possibilities to...
The proportion of patients hospitalized for heart failure (HF) with preserved left ventricular ejection fraction...
A unique study on the treatment results of migraine patients led Terveystalo to develop the...
In migraine, co-occurrence of two or more diseases or conditions is typical. Asthma and allergies,...
A new real world evidence study on Idiopathic pulmonary fibrosis (IPF) describes the high disease...
Chronic obstructive pulmonary disease is one of the leading causes of mortality and morbidity worldwide....
Healthcare provides various types of Real World Data (RWD) that can be used to generate...
The Burden of Migraine Study continues The study ‘Migraine comorbidity and phenotypic disease networks in...
Medaffcon’s new real-world evidence study on the burden of adult asthma in Finland demonstrates the...
HIMSS & Health 2.0 European conference took place on 11-13.6.2019 in Helsinki. 3 000 professionals...
The high mortality rate of heart failure (HF) patients compared to age-matched controls highlights the...
New real-world evidence (RWE) based study shows that migraine nearly doubles the amount of healthcare...
Pricing and reimbursement in Finland Pharmaceuticals Pricing Board (PPB), operating under the Ministry of Social...
Medaffcon pioneering biobank and real-world evidence research efforts in Finland The newest Biobanking in Finland...
BC Platforms AG, a world leader in genomic data management and analytics, today announces that...
Recently established Finnish hospital biobanks have launched new research activity in Finland. Through the Finnish biobank...
Public health authorities and pharmaceutical companies have searched for alternative funding formulas to share the...
Analyzing electronic health record (EHR) data has already provided us with new insights in medical...
Medaffcon has in collaboration with the University of Eastern Finland assessed the operational status of...
Demonstrating that a health technology, e.g. a product, procedure or any intervention, is worth its...
Medaffcon has created a unique platform that collects information about innovative Finnish efforts and technologies...
Currently huge piles of health care data have been collected in Finland through national, regional...
Risk-sharing agreements (RSA) are one of the most interesting and debated topics in the Finnish...